Immix Biopharma, Inc. IMMX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s deferred tax assets and other non-current assets?
- Immix Biopharma, Inc. (IMMX) reported deferred tax assets and other non-current assets of $20.42K in Q1 2026.
- How has Immix Biopharma, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Immix Biopharma, Inc.'s deferred tax assets and other non-current assets decreased by 0.0% year-over-year, from $20.42K to $20.42K.
- What is the long-term trend for Immix Biopharma, Inc.'s deferred tax assets and other non-current assets?
- Over 2 years (2022 to 2025), Immix Biopharma, Inc.'s deferred tax assets and other non-current assets has grown at a 74.3% compound annual growth rate (CAGR), from $6.72K to $20.42K.